Specifically, we ran 1000 bootstrapped regression models in ADNI Aβ+ (i.e., discovery sample) to determine beta-estimates for the association between cognitive-domain-specific tau-PET and cognitive decline, controlling for age, sex, clinical status, and APOE4 status. The gene discussed is MAPT; the disease is Mental deterioration.